Hyper Arc technology for stereotactic radiosurgery treatment of brain metastases

被引：0
作者：
Marija, Skoblar Vidmar [1 ,2 ]
机构：
[1] Onkol Inst Ljubljana, Sektor Radioterapije, Zaloska Cesta 2, Ljubljana, Slovenia
[2] Univ Ljubljani, Med Fak, Vrazov Trg 2, Ljubljana 1000, Slovenia
来源：
ONKOLOGIJA | 2023年 / 27卷 / 01期
关键词：
Hyper Arc; stereotactic radiosurgery; definition; brain metastases; neurocognitive function; RADIATION-THERAPY; RADIOTHERAPY;
D O I：
10.25670/oi2023-003on
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Hyper Arc is an innovative software that was introduced at the Institute of Oncology Ljubljana in June 2020. It enables high-precision treatment of multiple lesions in the brain with a single isocenter - the number of targets that can be addressed with one isocenter seems to be unlimited. It is most useful in the local treatment of brain metastases, which are an increasingly frequent cause of morbidity and mortality in patients with malignant diseases. Based on the latest research and guidelines, stereotactic radiosurgery is considered the primary choice to improve survival and may be the best treatment choice for multiple brain metastases. Local control of each irradiated lesion and possible late toxicity are increasingly clinically important, which may affect not only survival but also neurocognitive function and quality of life.
引用
收藏
页码：20 / 23
页数：4
相关论文
共 22 条
  • [1] Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
    Andrews, DW
    Scott, CB
    Sperduto, PW
    Flanders, AE
    Gaspar, LE
    Schell, MC
    Werner-Wasik, M
    Demas, W
    Ryu, J
    Bahary, JP
    Souhami, L
    Rotman, M
    Mehta, MP
    Curran, WJ
    [J]. LANCET, 2004, 363 (9422) : 1665 - 1672
  • [2] Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases - A randomized controlled trial
    Aoyama, Hidefumi
    Shirato, Hiroki
    Tago, Masao
    Nakagawa, Keiichi
    Toyoda, Tatsuya
    Hatano, Kazuo
    Kenjyo, Masahiro
    Oya, Natsuo
    Hirota, Saeko
    Shioura, Hiroki
    Kunieda, Etsuo
    Inomata, Taisuke
    Hayakawa, Kazushige
    Katoh, Norio
    Kobashi, Gen
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21): : 2483 - 2491
  • [3] A comparison of dose distributions of proton and photon beams in stereotactic conformal radiotherapy of brain lesions
    Baumert, BG
    Lomax, AJ
    Miltchev, V
    Davis, JB
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (05): : 1439 - 1449
  • [4] Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study
    Cagney, Daniel N.
    Martin, Allison M.
    Catalano, Paul J.
    Redig, Amanda J.
    Lin, Nancy U.
    Lee, Eudocia Q.
    Wen, Patrick Y.
    Dunn, Ian F.
    Bi, Wenya Linda
    Weiss, Stephanie E.
    Haas-Kogan, Daphne A.
    Alexander, Brian M.
    Aizer, Ayal A.
    [J]. NEURO-ONCOLOGY, 2017, 19 (11) : 1511 - 1521
  • [5] Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
    Chang, Eric L.
    Wefel, Jeffrey S.
    Hess, Kenneth R.
    Allen, Pamela K.
    Lang, Frederick F.
    Kornguth, David G.
    Arbuckle, Rebecca B.
    Swint, J. Michael
    Shiu, Almon S.
    Maor, Moshe H.
    Meyers, Christina A.
    [J]. LANCET ONCOLOGY, 2009, 10 (11) : 1037 - 1044
  • [6] Mechanisms and Therapy for Cancer Metastasis to the Brain
    Franchino, Federica
    Ruda, Roberta
    Soffietti, Riccardo
    [J]. FRONTIERS IN ONCOLOGY, 2018, 8
  • [7] Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
    Guckenberger, Matthias
    Baus, Wolfgang W.
    Blanck, Oliver
    Combs, Stephanie E.
    Debus, Juergen
    Engenhart-Cabillic, Rita
    Gauer, Tobias
    Grosu, Anca L.
    Schmitt, Daniela
    Tanadini-Lang, Stephanie
    Moustakis, Christos
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (05) : 417 - 420
  • [8] Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
    Kocher, Martin
    Soffietti, Riccardo
    Abacioglu, Ufuk
    Villa, Salvador
    Fauchon, Francois
    Baumert, Brigitta G.
    Fariselli, Laura
    Tzuk-Shina, Tzahala
    Kortmann, Rolf-Dieter
    Carrie, Christian
    Ben Hassel, Mohamed
    Kouri, Mauri
    Valeinis, Egils
    van den Berge, Dirk
    Collette, Sandra
    Collette, Laurence
    Mueller, Rolf-Peter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) : 134 - 141
  • [9] A case-matched study of stereotactic radiosurgery for patients with brain metastases: comparing treatment results for those with versus without neurological symptoms
    Koiso, Takao
    Yamamoto, Masaaki
    Kawabe, Takuya
    Watanabe, Shinya
    Sato, Yasunori
    Higuchi, Yoshinori
    Yamamoto, Tetsuya
    Matsumura, Akira
    Kasuya, Hidetoshi
    Barfod, Bierta E.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2016, 130 (03) : 581 - 590
  • [10] Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases
    Kondziolka, D
    Patel, A
    Lunsford, LD
    Kassam, A
    Flickinger, JC
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (02): : 427 - 434
123